НовостиBenzingaCanaccord Genuity Maintains Buy on Niagen Bioscience, Lowers Price Target to $7 Canaccord Genuity Maintains Buy on Niagen Bioscience, Lowers Price Target to $7 Benzinga 2026.11.06 19:24 (GMT+0) Открыть на Benzinga Другие новости